Efficacy, Safety, and Tolerability of Atogepant for the Prevention of Chronic Migraine

From clinicaltrials.gov:

This clinical trial is studying an investigational drug that may be able to help people living with chronic migraines
Inclusion criteria:

• Aged 18 to 80 years old
• At least a 1-year history of diagnosed chronic migraines
• 15 or more headache days per month without the loss of consciousness or retinal migraines
• Currently taking no more than 1 medication to prevent migraines

Duration: Total study participation will last about 20 weeks, which includes up to 8 visits to the study clinic. If eligible, you will be asked to take either the study drug or placebo once a day, or twice a day for the duration of the study.

Compensation: There is no compensation for this study. However, costs related to participation in the study, such as travel and meals during visit days, will be reimbursed.

More information